ArticleFrontiers in immunology2025

Promiscuous class II-binding SARS-CoV-2-nuc derived vaccine-peptide induced extensive conventional, innate and unconventional T cell responses.

Naomi Krickeberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.